NO20004143L - Pharmaceutical combinations with tramadol - Google Patents

Pharmaceutical combinations with tramadol

Info

Publication number
NO20004143L
NO20004143L NO20004143A NO20004143A NO20004143L NO 20004143 L NO20004143 L NO 20004143L NO 20004143 A NO20004143 A NO 20004143A NO 20004143 A NO20004143 A NO 20004143A NO 20004143 L NO20004143 L NO 20004143L
Authority
NO
Norway
Prior art keywords
tramadol
pharmaceutical combinations
pharmaceutical
combinations
Prior art date
Application number
NO20004143A
Other languages
Norwegian (no)
Other versions
NO327860B1 (en
NO20004143D0 (en
Inventor
Marc Raber
Helmut Momberger
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO20004143D0 publication Critical patent/NO20004143D0/en
Publication of NO20004143L publication Critical patent/NO20004143L/en
Publication of NO327860B1 publication Critical patent/NO327860B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/133Amines having hydroxy groups, e.g. sphingosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
NO20004143A 1998-02-21 2000-08-18 Use of pharmaceutical combinations with tramadol for the manufacture of a medicament. NO327860B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19807535A DE19807535A1 (en) 1998-02-21 1998-02-21 Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying
PCT/DE1999/000428 WO1999042095A1 (en) 1998-02-21 1999-02-17 Pharmaceutical combinations containing tramadol

Publications (3)

Publication Number Publication Date
NO20004143D0 NO20004143D0 (en) 2000-08-18
NO20004143L true NO20004143L (en) 2000-09-27
NO327860B1 NO327860B1 (en) 2009-10-05

Family

ID=7858642

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004143A NO327860B1 (en) 1998-02-21 2000-08-18 Use of pharmaceutical combinations with tramadol for the manufacture of a medicament.

Country Status (26)

Country Link
EP (1) EP1056448B1 (en)
JP (1) JP2002503689A (en)
KR (1) KR100567154B1 (en)
CN (1) CN1141937C (en)
AR (1) AR018102A1 (en)
AT (1) ATE257700T1 (en)
AU (1) AU748993B2 (en)
BG (1) BG64888B1 (en)
BR (1) BR9909211A (en)
CZ (1) CZ291941B6 (en)
DE (2) DE19807535A1 (en)
DK (1) DK1056448T3 (en)
EA (1) EA002166B1 (en)
ES (1) ES2212549T3 (en)
HK (1) HK1035143A1 (en)
HU (1) HU225656B1 (en)
IL (1) IL137505A (en)
NO (1) NO327860B1 (en)
NZ (1) NZ506020A (en)
PL (1) PL204075B1 (en)
PT (1) PT1056448E (en)
SK (1) SK284937B6 (en)
TR (1) TR200002411T2 (en)
TW (1) TWI228040B (en)
WO (1) WO1999042095A1 (en)
ZA (1) ZA991212B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002531431A (en) * 1998-12-02 2002-09-24 ダーウィン・ディスカバリー・リミテッド Therapeutic products and their use
DE19940944B4 (en) * 1999-08-31 2006-10-12 Grünenthal GmbH Retarded, oral, pharmaceutical dosage forms
WO2001064202A2 (en) * 2000-03-01 2001-09-07 Euro-Celtique S.A. Tramadol for the treatment of functional gastrointestinal disorders
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
DE10108122A1 (en) 2001-02-21 2002-10-02 Gruenenthal Gmbh Medicines based on tramadol
DE10361596A1 (en) * 2003-12-24 2005-09-29 Grünenthal GmbH Process for producing an anti-abuse dosage form
DE102004020220A1 (en) * 2004-04-22 2005-11-10 Grünenthal GmbH Process for the preparation of a secured against misuse, solid dosage form
US7553858B2 (en) * 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
EP2124556B1 (en) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmaceutical compositions
EP3090743A1 (en) 2008-01-09 2016-11-09 Charleston Laboratories, Inc. Pharmaceutical compositions for treating headache and eliminating nausea
ES2563061T3 (en) 2008-04-28 2016-03-10 Zogenix, Inc. New formulations for the treatment of migraine
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
CN106413717A (en) * 2014-04-10 2017-02-15 查尔斯顿实验室公司 Pharmaceutical compositions
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
CA3047088A1 (en) * 2016-12-15 2018-06-21 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis
JP7195660B1 (en) 2021-09-09 2022-12-26 壽製薬株式会社 Orally disintegrating tablet

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
FR2712809B1 (en) * 1993-11-26 1996-04-12 Union Pharma Scient Appl New pharmaceutical composition intended for the preparation of a stable powder containing, as active ingredient, a combination of acetylsalicylic acid and metoclopramide.
FR2720936B1 (en) * 1994-06-08 1997-04-30 Synthelabo Powders based on metoclopramide and paracetamol or acetylsalicylic acid derivatives.
GB9523566D0 (en) * 1995-11-17 1996-01-17 Euro Celtique Sa Pharmaceutical formulation
FR2741532B1 (en) * 1995-11-28 1998-08-21 Bouchara Sa NOVEL PHARMACEUTICAL COMPOSITIONS WITH ANTIMIGRAINE ACTION AND THEIR METHOD OF PREPARATION
GB2313309B (en) * 1996-05-24 2000-01-26 Ninh Thuy On Pharmaceutical compositions comprising a nonsteroidal anti-inflammatory drug and domperidone in the treatment of migraine

Also Published As

Publication number Publication date
KR20010041110A (en) 2001-05-15
BR9909211A (en) 2000-11-14
HUP0100964A3 (en) 2003-09-29
TWI228040B (en) 2005-02-21
BG104758A (en) 2001-04-30
WO1999042095A1 (en) 1999-08-26
DE19807535A1 (en) 1999-08-26
AU748993B2 (en) 2002-06-13
CN1141937C (en) 2004-03-17
AU3514899A (en) 1999-09-06
DK1056448T3 (en) 2004-05-17
EP1056448A1 (en) 2000-12-06
CN1291092A (en) 2001-04-11
AR018102A1 (en) 2001-10-31
NO327860B1 (en) 2009-10-05
CZ291941B6 (en) 2003-06-18
HU225656B1 (en) 2007-05-29
EP1056448B1 (en) 2004-01-14
SK12172000A3 (en) 2001-04-09
CZ20002939A3 (en) 2000-12-13
TR200002411T2 (en) 2000-12-21
HUP0100964A2 (en) 2001-08-28
KR100567154B1 (en) 2006-04-04
ZA991212B (en) 1999-08-03
NO20004143D0 (en) 2000-08-18
EA200000862A1 (en) 2001-02-26
PT1056448E (en) 2004-05-31
HK1035143A1 (en) 2001-11-16
PL342546A1 (en) 2001-06-18
NZ506020A (en) 2002-05-31
ATE257700T1 (en) 2004-01-15
IL137505A0 (en) 2001-07-24
PL204075B1 (en) 2009-12-31
EA002166B1 (en) 2001-12-24
IL137505A (en) 2005-07-25
BG64888B1 (en) 2006-08-31
JP2002503689A (en) 2002-02-05
SK284937B6 (en) 2006-02-02
ES2212549T3 (en) 2004-07-16
DE59908305D1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
DK1025241T4 (en) Protease variants with multiple substitutions
ID27415A (en) PHARMACEUTICAL COMPOSITION
DE60009395D1 (en) VIEW
ID25977A (en) DIAPON ONCE USE
ID24555A (en) DIAPON ONCE USE
ID23076A (en) DIAPON ONCE USE
ATE341990T1 (en) SIGMIDOSCOPE
ID27841A (en) THERAPEUTIC BIARILS
ID29089A (en) MOKSIFLOXASIN PHARMACEUTICAL PROPERTIES
ID29262A (en) PHARMACEUTICAL COMPOSITION
DK1466615T3 (en) Pharmaceutical preparation
ID23083A (en) DIAPON ONCE USE
DK1056448T3 (en) Pharmaceutical combinations with tramadol
ID27201A (en) PHARMACEUTICAL COMPOSITION
ATE262513T1 (en) BENZOYLPYRIDAZINE
DE1118098T1 (en) MEHRFACHFLUSSIGELEKTROSPRÜHSCHNITTSTELLE
DE19842103B4 (en) Stanznietzuführung
DK1051156T3 (en) Pharmaceuticals
FI980856A0 (en) Andningsskydd utrustad med en identifierare
IS5877A (en) New preparation
IS5879A (en) New preparation
DE29819079U1 (en) Kombuchalyophilisate
ATA126298A (en) VERPUFFUNGSKLAPPE
SE9801216D0 (en) Pharmaceuticals
ID26084A (en) AMINO ANTRASICLINON HERITIES

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees